Alfacell Corp (NASDAQOTH:ACEL)

CAPS Rating: No stars 0.00

A biopharmaceutical company, primarily engaged in the discovery and development of a new therapeutic class of drugs for the treatment of cancer and other pathological conditions.

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

81 Outperform
6 Underperform
 

All-Star Players

7 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top ACEL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

HAE3 (23.91)
Submitted March 24, 2008

This stock is a real sleeper.

zzlangerhans (99.78)
Submitted September 08, 2007

I'm definitely running against the grain on this one but I don't think the phase III trial of onconase will be positive. Phase III trials which are the result of data mining from other failed phase III trials do not have a good track record. Since… More

ACEL VS S&P 500 (SPY)

Fools bullish on ACEL are also bullish on:

Fools bearish on ACEL are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about ACEL.

Recs

1
Member Avatar HAE3 (23.91) Submitted: 3/24/2008 2:10:47 PM : Outperform Start Price: $2.40 ACEL Score: -211.98

This stock is a real sleeper.

Recs

0
Member Avatar Quoinintl (< 20) Submitted: 1/24/2008 6:15:33 PM : Outperform Start Price: $2.60 ACEL Score: -211.21

fda approval...oncanase!!

Recs

2
Member Avatar SAVERITELIQ (< 20) Submitted: 1/24/2008 4:45:30 PM : Outperform Start Price: $2.60 ACEL Score: -211.21

History will be made. New cancer drug finishing successful Phase III trials, hopefully will get FDA approval before end of 2008.

Low float, no gaps to fill, just successfully tested the 200 day moving average.

Leaderboard

Find the members with the highest scoring picks in ACEL.

Score Leader

j55555

j55555 (< 20) Score: +199.12

The Score Leader is the player with the highest score across all their picks in ACEL.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
j55555 < 20 7/30/2007 Underperform 3W $2.24 -97.77% +101.35% +199.12 0 Comment
jmbailey2000 66.06 4/20/2007 Underperform 1Y $2.42 -97.93% +99.21% +197.14 0 Comment
seraph0 < 20 9/13/2007 Underperform 5Y $2.18 -97.71% +97.81% +195.51 0 Comment
Ernbo6 51.84 5/8/2007 Underperform 3Y $2.63 -98.10% +96.32% +194.42 0 Comment
SueMe100 < 20 6/4/2007 Underperform 3W $2.52 -98.02% +92.21% +190.22 0 Comment
Flark44 32.37 7/18/2007 Underperform NS $2.49 -97.99% +90.45% +188.44 0 Comment
In2lose < 20 7/19/2007 Outperform NS $2.49 -97.99% +89.33% -187.32 0 Comment
Ratifyer 40.01 6/1/2007 Outperform 1Y $2.85 -98.25% +91.78% -190.03 1 Comment
Megalomania < 20 6/20/2007 Outperform 3M $2.21 -97.74% +92.73% -190.47 0 Comment
stockmikelong 84.65 7/10/2007 Outperform 5Y $2.48 -97.98% +92.95% -190.93 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ACEL.

Advertisement